Suppr超能文献

50岁以上年龄组骨质疏松性髋部骨折合并骨软化症

Coexistence of Osteomalacia in Osteoporotic Hip Fractures in More Than 50 Years Age Group.

作者信息

Kumar Karmesh, Bhayana Himanshu, Vaiphei Kim, Chouhan Devendra, Kanojia Rajendra Kumar, Bhadada Sanjay

机构信息

Department of Orthopaedics, PGIMER, Chandigarh, 160012 India.

Department of Histopathology, PGIMER, Chandigarh, 160012 India.

出版信息

Indian J Orthop. 2021 Jan 15;55(3):614-620. doi: 10.1007/s43465-020-00323-z. eCollection 2021 Jun.

Abstract

INTRODUCTION

Osteomalacia is a hitherto common orthopaedic condition and is commonly coexists with osteoporosis. However, the identification of osteomalacia always slips under the radar and more emphasis is given to diagnosis and management of osteoporosis. Identification of osteomalacia is equally relevant as management of the osteoporotic fractures is different with or without osteomalacia.

METHODS

This was a prospective study design that included patients 50 years or above of either sex presented with proximal femur fractures. Osteoporosis was identified by DEXA scan of hip and lumbar spine. Metabolic tests including serum calcium, phosphorus, ALP and vitamin D levels were done. Histopathological diagnosis of osteomalacia was performed on bony tissues that were taken during surgery from a site adjacent to the fracture and histological examination was performed on non-decalcified paraffin sections using special stains.

RESULTS

A total of 45 patients was included in study. Mean age was 68.7 years (53-85 years). Abnormal values of serum calcium, phosphorus, ALP, vitamin D were noted in 44.4%, 22.2%, 53.3% and 48.9% patients, respectively. On histopathology, 73.17% patients showed osteomalacia. No significant correlation was found between serum biochemical markers and histopathology except with serum Vitamin D ( value - 0.004).

CONCLUSION

The majority of patients with osteoporotic hip fractures had coexisting osteomalacia. Abnormal biochemical values were not significantly associated with osteomalacia. Hence, histopathology remains the gold standard for the diagnosis of osteomalacia. Further research is needed to identify a biomarker that may enable the clinician to diagnosis and treat osteomalacia well in time.

摘要

引言

骨软化症是一种至今仍常见的骨科病症,常与骨质疏松症并存。然而,骨软化症的诊断往往被忽视,更多的重点放在了骨质疏松症的诊断和治疗上。骨软化症的诊断同样重要,因为无论是否存在骨软化症,骨质疏松性骨折的治疗方法都有所不同。

方法

这是一项前瞻性研究设计,纳入了50岁及以上的股骨近端骨折患者,不限性别。通过髋部和腰椎的双能X线吸收法(DEXA)扫描来诊断骨质疏松症。进行了包括血清钙、磷、碱性磷酸酶(ALP)和维生素D水平在内的代谢测试。对手术中从骨折部位附近获取的骨组织进行骨软化症的组织病理学诊断,并使用特殊染色对未脱钙的石蜡切片进行组织学检查。

结果

共有45名患者纳入研究。平均年龄为68.7岁(53 - 85岁)。血清钙、磷、ALP、维生素D值异常的患者分别占44.4%、22.2%、53.3%和48.9%。组织病理学检查显示,73.17%的患者患有骨软化症。除血清维生素D外(值为 - 0.004),未发现血清生化标志物与组织病理学之间存在显著相关性。

结论

大多数骨质疏松性髋部骨折患者同时存在骨软化症。生化值异常与骨软化症无显著相关性。因此,组织病理学仍然是骨软化症诊断的金标准。需要进一步研究以确定一种生物标志物,使临床医生能够及时诊断和治疗骨软化症。

相似文献

6
Hypovitaminosis D in patients with osteoporotic hip fractures.骨质疏松性髋部骨折患者的维生素D缺乏症
J Clin Orthop Trauma. 2019 Jul-Aug;10(4):768-773. doi: 10.1016/j.jcot.2018.06.007. Epub 2018 Jun 22.

本文引用的文献

4
Safety issues with bisphosphonate therapy for osteoporosis.双膦酸盐治疗骨质疏松症的安全性问题。
Rheumatology (Oxford). 2014 Jan;53(1):19-31. doi: 10.1093/rheumatology/ket236. Epub 2013 Jul 9.
5
Osteoporosis in Asia: a call to action.亚洲骨质疏松症:行动呼吁。
Curr Osteoporos Rep. 2012 Dec;10(4):245-7. doi: 10.1007/s11914-012-0114-3.
10
Osteoporosis in Indians.印度人的骨质疏松症
Indian J Med Res. 2008 Mar;127(3):263-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验